Showing results (11-20 of 281) with videos related to
Sort By:
Pageof 29
Therapeutic Advances in Hematology|April 5, 2013
Allogeneic transplant for chronic myeloid leukemia in 2010Jerald P RadichCancer|July 1, 2011
Measuring response to BCR-ABL inhibitors in chronic myeloid leukemiaJerald P RadichHematology/Oncology Clinics of North America|November 8, 2011
The biology of chronic myelogenous leukemia progression: who, what, where, and why?Jerald P RadichClinical Lymphoma & Myeloma|March 27, 2007
Monitoring patients with chronic myeloid leukemia receiving Abl tyrosine kinase inhibitor therapyVivian Oehler, Jerald P RadichJournal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
Monitoring chronic myelogenous leukemia in the age of tyrosine kinase inhibitorsJerald P Radich, Vivian OehlerHematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous LeukemiaDEREK L. Stirewalt, JERALD P. RadichCurrent Oncology Reports|August 5, 2003
Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemiaVivian G Oehler, Jerald P RadichHematology/Oncology Clinics of North America|July 5, 2017
Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid LeukemiaJerald P Radich, Michael J MauroNature Reviews. Cancer|September 3, 2003
The role of FLT3 in haematopoietic malignanciesDerek L Stirewalt, Jerald P RadichPageof 29